Brian K. England, MD

Education

  • 1987-1989 / Emory University, Fellowship, Nephrology
  • 1987-1988 / Emory University, Chief Medical Resident
  • 1983-1986 / Emory University, Residency, Internal Medicine
  • 1979-1983 / University of Louisville, Doctor of Medicine
  • 1975-1979 / University of Louisville, Bachelor of Science, Zoology

Work Experience

  • 1996-Present / Clinical Nephrologist, Mountain Kidney and Hypertension Associates, PA
  • 1989-1996 / Associate Professor of Medicine, Emory University School of Medicine
  • 1986-1987 / Staff Physician, Georgia Sickle Cell Clinic, Grady Memorial Hospital

Credentials

  • Medical License / North Carolina Physician License - 9600527
  • Certification / North Carolina Medical Board – 72419
  • American Board of Internal Medicine, 1986
  • American Board of Nephrology, 2010, 2020

Hospital Affiliations

  • Mission-St. Joseph's Health System
  • Pardee Memorial Hospital
  • Care Partners Rehabilitation Hospital
  • Blue Ridge Regional Hospital
  • McDowell Hospital
  • Transylvania Regional Hospital
  • Park Ridge Hospital
  • Highlands-Cashiers Regional Hospital
  • Angel Medical Center

Professional Affiliations / Committees

  • American Society of Nephrology
  • Renal Physicians Association
  • National Kidney Foundation
  • American Society of Hypertension
  • 2010-Present / Adjunct Professor, Department of Medicine, UNC School of Medicine, Chapel Hill
  • 2006-2015 / Board of Directors, Mission Health Care Systems
  • 2007-2013 / Chair of Quality Committee of the Board, Mission Health, Care Systems
  • 1999-2006 / Chief of Adult Medicine Service Line, Mission Hospital

Honors and Awards

  • Phi Kappa Phi Honor Society
  • Woodcock Society
  • Alpha Omega Alpha Medical Honor Society
  • Best House Officer by Emory School of Medicine, Class of 1988

Research / Grants

  • Principal Investigator
    • Veterans Administration Merit Review, Changes in Enzyme Activity and Gene Transcription in Acidosis and Uremia
  • Co-Investigator
    • National Institutes of Health - Modification of Diet in Renal Disease
  • Sub-Investigator
    • START-CKD: Strategies Using Darbepoetin alfa to Avoid Transfusions in Chronic Kidney Disease
  • Sub-Investigator
    • A Randomized, Double-Blinded, Placebo-Controlled, Crossover, Multicenter Phase III Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in Chronic Kidney Disease Patients Receiving Chronic Hemodialysis
  • Sub-Investigator
    • Open Label Uncontrolled Extension Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in Chronic Kidney Disease Patients Receiving Chronic Hemodialysis
  • Sub-Investigator
    • Ferumoxytol for Anemia of CKD Trial (FACT): A Phase IV, Open-Label, Multicenter Trial, with MRI Substudy, of Repeated Doses of Ferumoxytol Compared with Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA) in Chronic Kidney Disease (CKD) Patients on Hemodialysis
Back To Top